Zoetis Inc (ZTS)
174.02
+0.32
(+0.18%)
USD |
NYSE |
May 17, 16:00
174.02
0.00 (0.00%)
After-Hours: 20:00
Zoetis Price to Book Value: 15.70 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 15.70 |
| May 16, 2024 | 15.67 |
| May 15, 2024 | 15.63 |
| May 14, 2024 | 15.23 |
| May 13, 2024 | 15.15 |
| May 10, 2024 | 15.25 |
| May 09, 2024 | 15.17 |
| May 08, 2024 | 14.88 |
| May 07, 2024 | 15.20 |
| May 06, 2024 | 14.97 |
| May 03, 2024 | 15.07 |
| May 02, 2024 | 15.09 |
| May 01, 2024 | 14.30 |
| April 30, 2024 | 14.37 |
| April 29, 2024 | 14.41 |
| April 26, 2024 | 14.29 |
| April 25, 2024 | 13.85 |
| April 24, 2024 | 13.63 |
| April 23, 2024 | 13.51 |
| April 22, 2024 | 13.15 |
| April 19, 2024 | 13.24 |
| April 18, 2024 | 13.83 |
| April 17, 2024 | 13.73 |
| April 16, 2024 | 13.82 |
| April 15, 2024 | 13.53 |
| Date | Value |
|---|---|
| April 12, 2024 | 13.55 |
| April 11, 2024 | 14.70 |
| April 10, 2024 | 14.74 |
| April 09, 2024 | 15.10 |
| April 08, 2024 | 14.97 |
| April 05, 2024 | 14.98 |
| April 04, 2024 | 14.95 |
| April 03, 2024 | 14.72 |
| April 02, 2024 | 14.91 |
| April 01, 2024 | 15.09 |
| March 31, 2024 | |
| March 28, 2024 | 15.47 |
| March 27, 2024 | 15.42 |
| March 26, 2024 | 15.16 |
| March 25, 2024 | 15.36 |
| March 22, 2024 | 15.46 |
| March 21, 2024 | 15.41 |
| March 20, 2024 | 15.65 |
| March 19, 2024 | 15.83 |
| March 18, 2024 | 15.62 |
| March 15, 2024 | 15.79 |
| March 14, 2024 | 15.91 |
| March 13, 2024 | 16.13 |
| March 12, 2024 | 16.60 |
| March 11, 2024 | 16.79 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
13.11
Minimum
Nov 03 2022
26.34
Maximum
Sep 02 2020
19.81
Average
19.95
Median
Apr 28 2021
Price to Book Value Benchmarks
| IDEXX Laboratories Inc | 28.61 |
| Pfizer Inc | 1.759 |
| ResMed Inc | 6.935 |
| Amgen Inc | 33.38 |
| Biogen Inc | 2.207 |
Price to Book Value Related Metrics
| PE Ratio | 33.54 |
| PS Ratio | 9.183 |
| PEG Ratio | 1.955 |
| Price to Free Cash Flow | 45.83 |
| Price | 174.02 |
| Earnings Yield | 2.98% |
| Market Cap | 79.42B |
| PEGY Ratio | 1.855 |
| Operating PE Ratio | 25.53 |
| Normalized PE Ratio | 33.18 |